E62 476
Meta-analysis of Observational Studies in Epidemiology (MOOSE)
group. JAMA 2000;283:2008–12.
[5]
Pierorazio PM, Johnson MH, Patel HD, et al. Management of renal masses and localized renal cancer [Internet]. Rockville, MD: Agency for Healthcare Research and Quality; 2016.[6] Campbell S, Uzzo RG, Allaf ME, et al. Renal mass and localized renal
cancer: AUA guideline. J Urol. In press.
http://dx.doi.org/10.1016/j. juro.2017.04.100 .[7]
Kutikov A, Egleston BL, Canter D, et al. Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model. J Urol 2012;188:2077–83.[8]
Weight CJ, Miller DC, Campbell SC, Derweesh IH, Lane BR, Messing EM. The management of a clinical t1b renal tumor in the presence of a normal contralateral kidney. J Urol 2013;189:1198–202.Ithaar H. Derweesh
a
Maria C. Mir
b
Riccardo Autorino
c,
*
a
Department of Urology, UC San Diego Health System, La Jolla, CA, USA
b
Urology Department, Instituto Valenciano Oncologia, Valencia, Spain
c
Division of Urology, Department of Surgery, Virginia Commonwealth
University Health Center, Richmond, VA, USA
*Corresponding author. Division of Urology, VCU Medical Center,
1200 East Broad st., 7th Floor, Richmond, VA 23298, USA.
Tel. +1 2165770609.
E-mail address:
ricautor@gmail.com(R. Autorino).
June 2, 2017
E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) e 6 1 – e 6 2
e62